ANI Pharma (ANIP) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
ANI Pharmaceuticals Reports First Quarter 2015 Financial Results
May 5, 2015 8:00 AM EDTBAUDETTE, Minn., May 5, 2015 /PRNewswire/ --Â ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three months ended March 31, 2015 and reaffirmed its revenue, non-GAAP EBITDA, and non-GAAP earnings per share guidance for 2015.
First Quarter 2015 Highlights Include:
First quarter net revenues of $18.8Â million, an increase of 72% as compared to $10.9 million for the same period in 2014. First quarter adjusted non-GAAP EBITDA of $11.5Â million, an increase of 170% as compared to $4.2 million for the same period in 2014. First quarter operating income of $9.6 million, an increase... More


